Harmony Biosciences Holdings (HRMY) Share-based Compensation Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 206.26% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -69.95% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 0.18% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.66% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 23.70% |
| 10 | Harmony Biosciences Holdings | 1.83 Bn | 1.19 Bn | 170.88 Mn | -15.03% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.03% |
| Dec 31, 2025 | -0.99% |
| Sep 30, 2025 | -4.18% |
| Jun 30, 2025 | 4.49% |
| Mar 31, 2025 | 20.25% |
| Dec 31, 2024 | 7.22% |
| Sep 30, 2024 | 43.87% |
| Jun 30, 2024 | 40.68% |
| Mar 31, 2024 | 58.42% |
| Dec 31, 2023 | 35.38% |
| Sep 30, 2023 | 14.21% |
| Jun 30, 2023 | 5.73% |
| Mar 31, 2023 | 41.77% |
| Dec 31, 2022 | 76.25% |
| Sep 30, 2022 | 49.38% |
| Jun 30, 2022 | 93.62% |
| Mar 31, 2022 | 42.36% |
| Dec 31, 2021 | 62.22% |
| Sep 30, 2021 | 250.68% |
| Jun 30, 2021 | 725.81% |
| Mar 31, 2021 | 584.42% |
| Dec 31, 2020 | -72.44% |
| Sep 30, 2020 | 226.78% |